首页|期刊导航|Oncology Research|Isoliquiritigenin Inhibits Triple-Negative Breast Cancer Progression via Targeting the IRF5/SLC7A5/IDO1-Mediated Tryptophan Metabolism Pathway
Oncology Research2025,Vol.33Issue(11):P.3543-3556,14.DOI:10.32604/or.2025.068292
Isoliquiritigenin Inhibits Triple-Negative Breast Cancer Progression via Targeting the IRF5/SLC7A5/IDO1-Mediated Tryptophan Metabolism Pathway
摘要
关键词
Interferon regulatory factor 5(IRF5)/triple-negative breast cancer/tryptophan metabolism/isoliquiritigenin/solute carrier family 7 member 5(SLC7A5)/indoleamine 2,3-dioxygenase 1(IDO1)分类
医药卫生引用本文复制引用
Sihai Duan,Xiaoyan Li,Cailu Song,Song Wu,Yunyun Tang,Qing Bao,Na Li,Hailin Tang..Isoliquiritigenin Inhibits Triple-Negative Breast Cancer Progression via Targeting the IRF5/SLC7A5/IDO1-Mediated Tryptophan Metabolism Pathway[J].Oncology Research,2025,33(11):P.3543-3556,14.基金项目
supported by the Science and Technology Program of Guangzhou(No.202103000020). (No.202103000020)